Reply to letter from Dr Bowring et al.

Abstract

all of which have been reported to have stronger associations with breast cancer than does HRT’. Cardiovascular concerns, they say, may be warranted, although largely in women at raised risk of CHD or in those who start HRT in their mid-60s. Otherwise, they too take a commonsense view and propose that ‘any woman worried about her health and longevity should quit smoking before she quits hormones’.